Who are Shugan Jieyu Capsules's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Entecavir+Fuzheng Huayu+TCM Granule, Sanjin tablets simulants, Shenlingcao Oral Liquid, Standard treatment+Xiyanping injection, Xingnaojing injection + Shuxuetong oral liquid, High dose WenXin keli.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/shugan-jieyu-capsules.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Shugan Jieyu Capsules — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Shugan Jieyu Capsules (Shugan Jieyu Capsules) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Traditional Chinese medicine. Area: Psychiatry.

phase 3 Traditional Chinese medicine Psychiatry Small molecule Live · refreshed every 30 min

Target snapshot

Shugan Jieyu Capsules (Shugan Jieyu Capsules) — Sichuan Jishengtang Pharmaceutical Co., Ltd.. Shugan Jieyu Capsules is a traditional Chinese medicine used to treat anxiety and insomnia.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Shugan Jieyu Capsules TARGET	Shugan Jieyu Capsules	Sichuan Jishengtang Pharmaceutical Co., Ltd.	phase 3	Traditional Chinese medicine
Entecavir+Fuzheng Huayu+TCM Granule	Entecavir+Fuzheng Huayu+TCM Granule	ShuGuang Hospital	marketed	Nucleoside reverse transcriptase inhibitor + Traditional Chinese Medicine herbal combination	HBV reverse transcriptase (entecavir component); multiple herbal constituents with unclear specific molecular targets
Sanjin tablets simulants	Sanjin tablets simulants	China Academy of Chinese Medical Sciences	marketed	Traditional Chinese medicine
Shenlingcao Oral Liquid	Shenlingcao Oral Liquid	West China Hospital	marketed	Traditional Chinese Medicine	Immune system
Standard treatment+Xiyanping injection	Standard treatment+Xiyanping injection	Jiangxi Qingfeng Pharmaceutical Co. Ltd.	marketed	Traditional Chinese medicine extract
Xingnaojing injection + Shuxuetong oral liquid	Xingnaojing injection + Shuxuetong oral liquid	Peking University Third Hospital	marketed	Traditional Chinese medicine combination / Herbal extract
High dose WenXin keli	High dose WenXin keli	Beijing Bozhiyin T&S Co., Ltd.	marketed	Traditional Chinese medicine / herbal formulation

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Traditional Chinese medicine class)

Shanghai University of Traditional Chinese Medicine · 2 drugs in this class
Jiangsu Famous Medical Technology Co., Ltd. · 2 drugs in this class
Guang'anmen Hospital of China Academy of Chinese Medical Sciences · 1 drug in this class
Sichuan Jishengtang Pharmaceutical Co., Ltd. · 1 drug in this class
Tasly Pharmaceutical Group Co., Ltd · 1 drug in this class
China Academy of Chinese Medical Sciences · 1 drug in this class
The First Affiliated Hospital of Guangzhou Medical University · 1 drug in this class
Dongzhimen Hospital, Beijing · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Shugan Jieyu Capsules — Competitive Intelligence Brief. https://druglandscape.com/ci/shugan-jieyu-capsules. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab